Your browser doesn't support javascript.
loading
An appendix to the 2012 IOF-ECTS guidelines for the management of glucocorticoid-induced osteoporosis.
Lekamwasam, S; Adachi, J D; Agnusdei, D; Bilezikian, J; Boonen, S; Borgström, F; Cooper, C; Perez, A Diez; Eastell, R; Hofbauer, L C; Kanis, J A; Langdahl, B L; Lesnyak, O; Lorenc, R; McCloskey, E; Messina, O D; Napoli, N; Obermayer-Pietsch, B; Ralston, S H; Sambrook, P N; Silverman, S; Sosa, M; Stepan, J; Suppan, G; Wahl, D A; Compston, J E.
Afiliación
  • Lekamwasam S; Centre for Metabolic Bone Diseases, Department of Medicine, Faculty of Medicine, Galle, Sri Lanka.
Arch Osteoporos ; 7: 25-30, 2012.
Article en En | MEDLINE | ID: mdl-23225278
The use of glucocorticoids in the treatment of medical disorders can lead to rapid bone loss and increased risk of fragility fracture. Updated clinical guidelines are needed that accommodate recent advances in fracture risk assessment and new pharmacological interventions to reduce fracture risk. This document serves as an appendix to the 2012 IOF-ECTS guidelines for the management of glucocorticoid-induced osteoporosis.
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Osteoporosis / Enfermedades Reumáticas / Antirreumáticos / Glucocorticoides Tipo de estudio: Guideline / Risk_factors_studies Límite: Humans Idioma: En Revista: Arch Osteoporos Año: 2012 Tipo del documento: Article País de afiliación: Sri Lanka Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Osteoporosis / Enfermedades Reumáticas / Antirreumáticos / Glucocorticoides Tipo de estudio: Guideline / Risk_factors_studies Límite: Humans Idioma: En Revista: Arch Osteoporos Año: 2012 Tipo del documento: Article País de afiliación: Sri Lanka Pais de publicación: Reino Unido